Management Change6 Aug 2026, 02:09 pm
Emcure Pharma Board Sees Director Changes and New Chairman
AI Summary
Emcure Pharmaceuticals Ltd announced significant changes in its Board composition. Mr. Berjis Desai, Chairman and Non-executive, Non-Independent Director, will cease to hold office upon the conclusion of the upcoming Annual General Meeting (AGM) due to his appointment to the National Commission for Minorities. The company also appointed Mr. Raghu Kumar as an Additional Director (Non-Executive and Independent) effective August 6, 2026, for a three-year term, subject to member approval. Furthermore, Mr. Satish Mehta, currently Managing Director & CEO, will assume the role of Chairman from the conclusion of the ensuing AGM, succeeding Mr. Desai.
Key Highlights
- Chairman Berjis Desai to retire post-AGM due to new national appointment.
- Raghu Kumar appointed as Additional Non-Executive Independent Director.
- Satish Mehta to become the new Chairman post-AGM.
- Changes align with SEBI LODR Regulations, noted by Nomination Committee.
Price Impact
More from EMCURE